Bioconstat
ActiveSummary
The computed 12-month bankruptcy probability of Bioconstat is 1.6% (moderate). The 2025 annual accounts show negative equity (-€125,415) and a net result of -€38,545. Equity is shrinking by about 34% per year across the filed financial years. Its solvency ranks better than 5% of 38,895 sector peers (NACE 70, financial year 2025). The company has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
10-02
NBB filing
Annual accounts filed
financial year 2025 · micro format · 10 days late
2025
31-01
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
30-06
Financial
Back to profitnet €11,267
Net result €11,267 after 5 loss-making years.
05-06
NBB filing
Annual accounts filed
financial year 2023 · micro format · 126 days late
2023
06-02
NBB filing
Annual accounts filed
financial year 2022 · micro format · 6 days late
2022
31-01
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
29-01
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
31-01
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
31-01
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
29-01
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
31-01
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 15 annual accounts filed, the latest 10 are here; all 15 are under Financials.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.